Teleflex Inc
TFX122.240USD
-0.050-0.04%
Close 12/24, 16:00（ET）Quotes delayed by 15 min
5.40BMarket Cap
LossP/E TTM
More Details of Teleflex Inc Company
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Teleflex Inc Info
Ticker SymbolTFX
Company nameTeleflex Inc
IPO dateMar 17, 1980
CEOKelly (Liam J)
Number of employees14100
Security typeOrdinary Share
Fiscal year-endMar 17
Address550 E Swedesford Rd
CityWAYNE
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code19087
Phone16102256800
Websitehttps://www.teleflex.com/usa/en/#
Ticker SymbolTFX
IPO dateMar 17, 1980
CEOKelly (Liam J)
Company Executives of Teleflex Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
50.99K
+3.03%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
10.22K
+10.84%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
6.54K
+18.04%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.66K
+9.70%
Mr. John C. Heinmiller
Mr. John C. Heinmiller
Independent Director
Independent Director
4.39K
+31.47%
Dr. Jaewon Ryu, M.D., J.D.
Dr. Jaewon Ryu, M.D., J.D.
Independent Director
Independent Director
3.08K
+95.06%
Ms. Neena M. Patil, J.D.
Ms. Neena M. Patil, J.D.
Independent Director
Independent Director
1.98K
+113.50%
Mr. John R. Deren
Mr. John R. Deren
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
50.99K
+3.03%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
10.22K
+10.84%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
6.54K
+18.04%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.66K
+9.70%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Vascular access
185.53M
23.76%
Interventional
170.02M
21.77%
Surgical
114.04M
14.60%
Anesthesia
96.39M
12.34%
OEM
78.67M
10.08%
Other
136.24M
17.45%
By RegionUSD
Name
Revenue
Proportion
Americas
525.64M
67.31%
EMEA
166.23M
21.29%
Asia Pacific
89.03M
11.40%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Vascular access
185.53M
23.76%
Interventional
170.02M
21.77%
Surgical
114.04M
14.60%
Anesthesia
96.39M
12.34%
OEM
78.67M
10.08%
Other
136.24M
17.45%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.05%
The Vanguard Group, Inc.
10.81%
T. Rowe Price Investment Management, Inc.
10.34%
Janus Henderson Investors
9.42%
AQR Capital Management, LLC
5.35%
Other
53.03%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.05%
The Vanguard Group, Inc.
10.81%
T. Rowe Price Investment Management, Inc.
10.34%
Janus Henderson Investors
9.42%
AQR Capital Management, LLC
5.35%
Other
53.03%
Shareholder Types
Shareholders
Proportion
Investment Advisor
57.71%
Investment Advisor/Hedge Fund
36.75%
Hedge Fund
9.11%
Pension Fund
1.76%
Sovereign Wealth Fund
1.36%
Research Firm
0.92%
Bank and Trust
0.57%
Family Office
0.37%
Individual Investor
0.34%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
1153
47.10M
106.58%
-5.30M
2025Q2
1158
48.67M
110.13%
-386.02K
2025Q1
1189
48.85M
110.52%
-721.30K
2024Q4
1180
47.47M
102.37%
-260.40K
2024Q3
1150
46.34M
98.36%
-1.83M
2024Q2
1147
46.98M
99.75%
-268.09K
2024Q1
1153
46.02M
97.70%
-1.89M
2023Q4
1170
46.05M
97.91%
-2.57M
2023Q3
1173
45.95M
97.77%
-3.19M
2023Q2
1201
46.87M
99.79%
-2.79M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
4.97M
11.25%
-385.28K
-7.19%
Jun 30, 2025
The Vanguard Group, Inc.
4.80M
10.86%
-269.49K
-5.32%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
5.94M
13.45%
-272.00K
-4.38%
Jun 30, 2025
Janus Henderson Investors
4.15M
9.39%
-176.31K
-4.08%
Jun 30, 2025
AQR Capital Management, LLC
409.32K
0.93%
+116.80K
+39.93%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
2.40M
5.44%
-373.80K
-13.46%
Jun 30, 2025
State Street Investment Management (US)
1.46M
3.3%
-69.05K
-4.52%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.24M
2.81%
+373.94K
+43.09%
Jun 30, 2025
Cooke & Bieler, L.P.
1.21M
2.73%
+148.44K
+14.04%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco S&P SmallCap Health Care ETF
3.37%
First Trust Indxx Medical Devices ETF
2.09%
First Trust Health Care Alphadex Fund
1.77%
State Street SPDR S&P Health Care Equipment ETF
1.7%
Zacks Small/Mid Cap ETF
0.85%
State Street SPDR S&P 600 Small Cap Value ETF
0.75%
iShares S&P Small-Cap 600 Value ETF
0.75%
Distillate Small/Mid Cash Flow ETF
0.7%
VictoryShares Small Cap Free Cash Flow ETF
0.68%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.67%
View more
Invesco S&P SmallCap Health Care ETF
Proportion3.37%
First Trust Indxx Medical Devices ETF
Proportion2.09%
First Trust Health Care Alphadex Fund
Proportion1.77%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.7%
Zacks Small/Mid Cap ETF
Proportion0.85%
State Street SPDR S&P 600 Small Cap Value ETF
Proportion0.75%
iShares S&P Small-Cap 600 Value ETF
Proportion0.75%
Distillate Small/Mid Cash Flow ETF
Proportion0.7%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.68%
iShares MSCI USA Small-Cap Min Vol Factor ETF
Proportion0.67%
Dividend
A total of
318.10M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Nov 06, 2025
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2025 going ex on Nov 14, 2025
Nov 14, 2025
Dec 15, 2025
Nov 14, 2025
Jul 31, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2025 going ex on Aug 15, 2025
Aug 15, 2025
Sep 15, 2025
Aug 15, 2025
May 12, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 16, 2025 going ex on May 20, 2025
May 20, 2025
Jun 16, 2025
May 20, 2025
Feb 27, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 17, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 17, 2025
Mar 07, 2025
Oct 31, 2024
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 16, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Dec 16, 2024
Nov 15, 2024
Aug 01, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 16, 2024 going ex on Aug 15, 2024
Aug 15, 2024
Sep 16, 2024
Aug 15, 2024
May 06, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 14, 2024 going ex on May 14, 2024
May 15, 2024
Jun 14, 2024
May 14, 2024
Feb 22, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 02, 2023
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2023 going ex on Nov 14, 2023
Nov 15, 2023
Dec 15, 2023
Nov 14, 2023
Aug 03, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2023 going ex on Aug 14, 2023
Aug 15, 2023
Sep 15, 2023
Aug 14, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Teleflex Inc?
The top five shareholders of Teleflex Inc are:
BlackRock Institutional Trust Company, N.A. holds 4.97M shares, accounting for 11.25% of the total shares.
The Vanguard Group, Inc. holds 4.80M shares, accounting for 10.86% of the total shares.
T. Rowe Price Investment Management, Inc. holds 5.94M shares, accounting for 13.45% of the total shares.
Janus Henderson Investors holds 4.15M shares, accounting for 9.39% of the total shares.
AQR Capital Management, LLC holds 409.32K shares, accounting for 0.93% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 4.97M shares, accounting for 11.25% of the total shares.
The Vanguard Group, Inc. holds 4.80M shares, accounting for 10.86% of the total shares.
T. Rowe Price Investment Management, Inc. holds 5.94M shares, accounting for 13.45% of the total shares.
Janus Henderson Investors holds 4.15M shares, accounting for 9.39% of the total shares.
AQR Capital Management, LLC holds 409.32K shares, accounting for 0.93% of the total shares.
What are the top three shareholder types of Teleflex Inc?
The top three shareholder types of Teleflex Inc are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Investment Management, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Investment Management, Inc.
How many institutions hold shares of Teleflex Inc (TFX)?
As of 2025Q3, 1153 institutions hold shares of Teleflex Inc, with a combined market value of approximately 47.10M, accounting for 106.58% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -3.56%.
What is the biggest source of revenue for Teleflex Inc?
In FY2025Q2, the Vascular access business generated the highest revenue for Teleflex Inc, amounting to 185.53M and accounting for 23.76% of total revenue.
